Year 2016 -

June 29, 2016

IPA Meeting with the FDA: Quality Forum Update, Washington DC.

May 13, 2016

Presentation to IGDRP: Licensing of Generic Products: Needs and Expectation of Industry, Strasbourg.

January 29, 2021

IPA Submission – USTR Special 301 Report

January 25, 2021

IPA Employee Safety Initiatives Report

March 28, 2021

Patient-centricity must drive the pharma sector

March 25, 2021

PCI introduces faculty-industry training programme for teachers to make students industry-ready after graduation

March 22, 2021

Teachers should have good knowledge of drug development through exposure to industry practices: Expert

March 19, 2021

Dr Reddy’s On Digitization Amid COVID-19, ‘Lights-Out’ Manufacturing

March 18, 2021

Underlying the challenges and opportunities

March 1, 2021

Pharma stalwarts demystify COVID-19 impact on industry

February 25, 2021

Realisation there in pharma industry to become self-reliant in API production: IPA

February 22, 2021

India Pharmaceutical Forum to focus on patients, Covid-19

February 18, 2021

Pharma is a jewel in India’s crown with long term growth opportunities

January 28, 2021

Innovation and collaboration will help Indian pharma leapfrog in the global value chain: Experts

January 25, 2021

Back to Growth: Pharmaceutical sector overview and interview with Sudarshan Jain, Secretary General, IPA

January 24, 2021

Union Budget 2021: Covid-19 pandemic underlines need for higher allocation for healthcare sector

January 23, 2021

Industry opens bag of expectations for Union Budget 2021-22

January 20, 2021

Drug manufacturers hope new US govt will see them as ‘allies’

No data found